0.2782  0.002 (0.69%)		09-17 15:39
Open: 0.3251 High: 0.3251 Volume: 1,380,977		Pre. Close: 0.2763 Low: 0.2535 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	0.38	1-year :	0.45
Resists	First :	0.32	Second :	0.38
Pivot price	0.31
Supports	First :	0.23	Second :	0.19
MAs	MA(5) :	0.28	MA(20) :	0.32
	MA(100) :	0.46	MA(250) :	1.08
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	24	D(3) :	15.4
RSI	RSI(14): 36.9
52-week	High :	3.21	Low :	0.23

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ TIVC ] has closed above bottom band by 9.8%. Bollinger Bands are 68.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.3 - 0.3	0.3 - 0.3
Low:	0.23 - 0.23	0.23 - 0.23
Close:	0.27 - 0.28	0.28 - 0.28

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Tue, 17 Sep 2024
Tivic Health partners with Fletcher Spaght for growth strategy - Investing.com

Tue, 17 Sep 2024
Tivic Health Accelerates VNS Commercial Strategy Development - Business Wire

Sat, 14 Sep 2024
Tivic Health names Lisa Wolf as interim CFO - MSN

Fri, 13 Sep 2024
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer - Business Wire

Fri, 13 Sep 2024
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer - StockTitan

Mon, 29 Jul 2024
Best Growth Stocks Releases In-Depth Analysis of Tivic Health Systems’ Growth Potential - Vancity Buzz

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	6 (M)
Shares Float	6 (M)
Held by Insiders	0.3 (%)
Held by Institutions	10 (%)
Shares Short	100 (K)
Shares Short P.Month	2,400 (K)

EPS	11.85
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.68
Profit Margin	0 %
Operating Margin	-861.5 %
Return on Assets (ttm)	-89.2 %
Return on Equity (ttm)	-183.7 %
Qtrly Rev. Growth	-13 %
Gross Profit (p.s.)	0
Sales Per Share	0.17
EBITDA (p.s.)	-1.09
Qtrly Earnings Growth	0 %
Operating Cash Flow	-7 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	0.02
PEG Ratio	0
Price to Book value	0.4
Price to Sales	1.53
Price to Cash Flow	-0.26

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.